首页> 外文期刊>Endocrine. >The influence of prehypertension, hypertension, and glycated hemoglobin on the development of type 2 diabetes mellitus in prediabetes: the Korean Genome and Epidemiology Study (KoGES)
【24h】

The influence of prehypertension, hypertension, and glycated hemoglobin on the development of type 2 diabetes mellitus in prediabetes: the Korean Genome and Epidemiology Study (KoGES)

机译:疗法,高血压和糖化血红蛋白对前奶奶油蛋白2型糖尿病发育的影响:韩国基因组和流行病学研究(Koges)

获取原文
获取原文并翻译 | 示例
           

摘要

Background It has been reported that elevated blood pressure (BP) was significantly associated with the increased risk for type 2 diabetes mellitus (T2DM). However, there is still limited information about the influence of BP on the risk for T2DM across the level of glycated hemoglobin (HbA1c). Method In a cohort of the Korean Genome and Epidemiology Study (KoGES), 2830 non-diabetic Korean adults with prediabetes defined by HbA1c level of 5.7-6.4% were followed-up for 10 years. Multivariate cox proportional hazards assumption was used to assess the risk for T2DM according to the baseline BP categories (normal, prehypertension and hypertension) and HbA1c level (low: 5.7-5.9% and high: 6.0-6.4%). Results The risk for T2DM significantly increased proportionally to BP categories (adjusted HR; reference in normal BP, 1.32 [1.10-1.59] in prehypertension and 1.61 [1.35-1.92] in hypertension). Subgroup analysis indicated that individuals with high HbA1c had the higher risk for T2DM than individuals with low HbA1c regardless of BP. Additionally, combined presence of hypertension and high HbA1c had the highest risk for T2DM (adjusted HR: 3.82 [3.00^.87]). In each systolic and diastolic BP level, the risk for T2DM significantly increased from systolic BPS130mmHg (adjusted HRs: 1.39 ([1.15-1.71]) and diastolic BP>80mmHg (adjusted HRs: 1.30 ([1.07-1.58]). Conclusion BP and HbA1c may be useful tools in identifying individuals with prediabetes more potentially predisposed to T2DM. Prospective studies should be considered to examine whether controlling BP actually lowers the risk for T2DM.
机译:背景技术据报道,血压升高(BP)与2型糖尿病(T2DM)的风险增加显着相关。然而,关于BP对血液血红蛋白(HBA1C)水平的T2DM风险影响的有限信息。韩国基因组和流行病学研究(Koges)的方法,2830名非糖尿病韩国成年人,由HBA1C级别为5.7-6.4%的预测进行了10年。多变量Cox比例危害假设用于评估根据基线BP类别(正常,毛发力和高血压)和HBA1C水平(低:5.7-5.9%和高:6.0-6.4%)的风险。结果T2DM的风险与BP类别比例增加(调整后的HR;正常BP中的参考,1.32 [1.35-1.59]高血压和高血压中的1.61 [1.35-1.92])。亚组分析表明,具有高HBA1C的个体的T2DM风险越高,无论BP如何,都有低HBA1c的个体。此外,高血压和高HBA1C的组合存在具有T2DM的最高风险(调整后的HR:3.82 [3.00 ^ .87])。在每个收缩性和舒张性BP水平中,T2DM的风险从收缩式BPS130MMHG显着增加(调节的HRS:1.39([1.15-1.71]和舒张压率高> 80mMHg(调节的HRS:1.30)。结论BP和HBA1C可能是识别与PrediaBetes更潜在的倾向于T2DM的个体的有用工具。应考虑前瞻性研究检查控制BP是否实际降低T2DM的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号